首页> 外文期刊>Journal of pediatric gastroenterology and nutrition >Virologic Responses to Add-on Adefovir Dipivoxil Treatment Versus Entecavir Monotherapy in Children With Lamivudine-resistant Chronic Hepatitis B
【24h】

Virologic Responses to Add-on Adefovir Dipivoxil Treatment Versus Entecavir Monotherapy in Children With Lamivudine-resistant Chronic Hepatitis B

机译:耐拉米夫定的慢性乙型肝炎儿童对阿德福韦酯联合依维卡韦单药治疗对阿德福韦酯的病毒学应答

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: The aim of the study was to compare the virologic response to adefovir (ADV) add-on therapy with switching to entecavir (ETV) monotherapy in children and adolescents with chronic hepatitis B (CHB) who have developed lamivudine (LAM) resistance during LAM treatment.
机译:目的:本研究的目的是比较在治疗期间对拉米夫定(LAM)产生耐药性的慢性乙型肝炎(CHB)儿童和青少年中,对阿德福韦(ADV)加用疗法与改用恩替卡韦(ETV)单一疗法的病毒学应答LAM治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号